Mineralocorticoid receptor blockade improves pulmonary hypertension and right ventricular function in bronchopulmonary dysplasia : a case report

2020 Cardiovascular Diagnosis and Therapy. All rights reserved..

Bronchopulmonary dysplasia (BPD) is a combined pulmonary vascular and parenchymal disease, representing the most common cause of chronic lung disease (CLD) in infancy. Pulmonary hypertension (PH) is frequently associated with BPD and-if persistent-substantially increases mortality. We report on a 4-month-old, former preterm infant with BPD, severe PH and right heart failure who greatly and rapidly improved clinical status and right ventricular (RV) function by means of blood biomarkers [N-terminal prohormone of brain natriuretic peptide (NT-pro-BNP), cardiac troponin T] and transthoracic echocardiography, following the addition of spironolactone and hydrochlorothiazide to the treatment regimen.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Cardiovascular diagnosis and therapy - 10(2020), 5 vom: 17. Okt., Seite 1686-1690

Sprache:

Englisch

Beteiligte Personen:

Giagnorio, Roberto [VerfasserIn]
Hansmann, Georg [VerfasserIn]

Links:

Volltext

Themen:

Bronchopulmonary dysplasia (BPD)
Case Reports
Case report
Hydrochlorothiazide (HCTZ)
Pulmonary hypertension (PH)
Spironolactone

Anmerkungen:

Date Revised 24.11.2020

published: Print

Citation Status PubMed-not-MEDLINE

doi:

10.21037/cdt.2020.02.05

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM31791782X